In GBA1-PD patient-derived macrophages, these PCs increased GCase protein levels, enhanced GCase activity, and reduced GluCer and GluSph substrate accumulation; in patient-derived dopaminergic neurons, they also lowered α-synuclein levels [52, 53, 55]. The gene discussed is GBA1; the disease is Parkinson disease.